Search results
Results From The WOW.Com Content Network
History Clinical trials Phase I trials On recommendation by the Subject Expert Committee (SEC) under the Indian drug regulator, the company conducted phase 1 clinical trials using 75 volunteers and submit safety and immunogenicity data for the committee's consideration before it proceeds to the second phase of the trial. Phase II and III trials On 12 August 2021, after evaluating the results ...
Soberana Plus. Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. Soberana Plus, technical name FINLAY-FR-1A, is a COVID-19 candidate vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. [1]